Syed Hamzavi, MD
MOHS-Micrographic Surgery · Clinton Twp, MINPI 1295780989
Payments from drug & device makers
Across 954 payments — averaging $5808.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$4.3M
- Janssen Research & Development, LLC$412K
- E.r. Squibb & Sons, L.L.C.$164K
- Amgen$119K
- Vanda Pharmaceuticals Inc.$109K
- AbbVie$107K
- plus $370K from 25 others
Across 5 payments — averaging $32,326 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nielsen Biosciences, Inc.$160K
- Eli Lilly$2K
What the payments were for
- Consulting fees$68016%
- Travel & lodging$1,65839%
- Food & beverage$1,80742%
- Education$1283%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 534 | $4,259,960 |
| Janssen Research & Development, LLC | 87 | $411,875 |
| E.r. Squibb & Sons, L.L.C. | 10 | $164,470 |
| Amgen | 7 | $118,639 |
| Vanda Pharmaceuticals Inc. | 44 | $108,626 |
| AbbVie | 51 | $107,444 |
| Eli Lilly | 12 | $93,764 |
| Pfizer | 45 | $83,020 |
| Kiniksa Pharmaceuticals, Ltd. | 81 | $78,706 |
| Merck | 1 | $55,363 |
| Arcutis Biotherapeutics, Inc. | 9 | $20,213 |
| Sun Pharmaceutical Industries Inc. | 4 | $18,008 |
| Sanofi US Services Inc. | 3 | $9,025 |
| Verrica Pharmaceuticals Inc. | 1 | $8,750 |
| Insmed, Inc. | 11 | $1,850 |
| Johnson & Johnson | 11 | $215 |
| Novartis | 12 | $190 |
| Kerecis Limited | 2 | $142 |
| Galderma Laboratories, L.p. | 1 | $124 |
| Genentech USA, Inc. | 7 | $107 |
| LEO Pharma Inc. | 7 | $101 |
| Bristol Myers Squibb | 2 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $42 |
| Convatec Inc. | 1 | $39 |
| UCB, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Boehringer Ingelheim | 1 | $27 |
| Dermavant Sciences, Inc. | 1 | $18 |
| Strata Skin Sciences, Inc. | 2 | $16 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$5,540,900 in reported general payments places this provider in the 95th percentile of 30 mohs-micrographic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 25 | $200,666 |
| Dupixent PenDupilumab | 11 | $41,535 |
| Fluorouracil | 68 | $4,006 |
| Metronidazole | 26 | $3,014 |
| Clobetasol Propionate | 61 | $2,438 |
| Betamethasone Dipropionate | 38 | $1,721 |
| Ketoconazole | 67 | $1,359 |
| Ammonium Lactate | 45 | $796 |
| Triamcinolone Acetonide | 91 | $784 |
| Clindamycin Phosphate | 23 | $580 |
| Hydrocortisone | 76 | $410 |
| Imiquimod | 16 | $362 |
| Cephalexin | 70 | $324 |
| Fluocinonide | 17 | $310 |
| Clotrimazole | 21 | $224 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Clinton Twp
- David OzogDetroit$276K
- Milad EshaqAnn Arbor$68K
- Bryan SofenRoyal Oak$35K
- Michael WhitworthWyandotte$13K
- David ByrdRochester Hills$10K
- Ryan JonesPortage$9K
- Abraham AbdulhakDearborn$8K
- Lindsay SklarWest Bloomfield$6K
- Luke NicholasRockford$4K
- Aaron CetnerWest Bloomfield$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.